Google Health is launching a free app that uses AI trained on more than 16,000 clinical dermatology cases and can identify hundreds of skin conditions, including cancers, with accuracy comparable to that of board-certified dermatologists in the U.S.

The principal deputy director of the Centers for Disease Control and Prevention is stepping down from her role, marking the second high-profile departure from the agency in the span of a month.

The Department of Health and Human Services has overturned a Trump-era rule that would have allowed healthcare providers to discriminate against patients based on sexual orientation or gender identity. 

A medical AI startup focused on breast cancer diagnostics has uncloaked from stealth mode, appointing an MD as CEO and concertedly promoting its initial software offering seven months after the FDA approved the product.

Walmart is advancing its healthcare capabilities with the acquisition of telehealth provider MeMD.

The FDA has approved an AI tool for speeding thyroid sonography workflows while, across the Atlantic, the European Union has OK’d an AI-based ultrasound device that guides nerve blocking as a form of local anesthesia

The last two weeks saw market clearances granted in Europe for AI-based software focused on remote patient monitoring, prostate oncology and real-time guidance of coronary stenting.

The Biden administration has backed the waiving of intellectual property protections for COVID-19 vaccines, supporting a proposal from the World Trade Organization to improve worldwide vaccinations against the deadly virus.